Cem Gorgun

Energizer
DISC Type : I

Director, Oncology Clinical Development at BioNTech SE

Cambridge, Massachusetts, United States

Overview

Cem Gorgun is a physician-scientist and oncology development leader with over 15 years of experience in the biopharmaceutical industry. As a Director at BioNTech, he focuses on immuno-oncology, bispecifics, and first-in-human clinical programs. He completed his post-doctoral fellowship at Harvards T. H. Chan School of Public Health.

Outside of his direct professional responsibilities, he has contributed to philanthropic causes. He is listed as a donor to the Turkish Philanthropy Funds, an organization dedicated to creating lasting change by supporting communities in Turkey and the US.

He has recently co-authored multiple publications on investigational bispecific antibody immunotherapies, including Acasunlimab, for treating metastatic non-small cell lung cancer.

Personality Overview

Big Picture Person

Imaginative

Believer

They are not always early adopters but can be pursuaded by leveraging strong relationships.  They are really good at seeing what the long-term impacts of their decisions could be. They are always positive and upbeat, so take their promises with a pinch of salt.

Topics They Care About

Immuno-Oncology
A core area of his expertise, reflected in his current role at BioNTech and numerous recent publications on bispecific antibodies and immunotherapies.
Bispecific Antibodies
His work and publications, such as those on Acasunlimab and BNT314, show a deep focus on developing and testing bispecific antibody platforms for cancer treatment.
Early Clinical Development
His role emphasizes first-in-human programs, and his prior experience at Takeda involved leading early-stage assets and cellular therapy programs.

Media Appearances

Cem has no verified media appearances

Work History

7-2023
Director, Oncology Clinical Development at BioNTech SE
7-2023
Global Clinical Lead at BioNTech SE
6-2021 - 7-2023
Medical Director, Oncology Clinical Science at Takeda Oncology
7-2020 - 6-2021
Scientific Director, Oncology Global Medical Affairs at Takeda Oncology
11-2017 - 7-2020
Assoc. Scientific Director Oncology Pipeline, Global Medical Affairs, at Takeda Oncology

Education

2000 - 2004
Post Doctoral Fellow from Harvard T.H. Chan School of Public Health
1993 - 1998
PhD Equil from Department of Medical Pharmacology, School of Medicine, Gazi University

More Information

Social Presence :

Prographics :

Exp : 21 Location : Cambridge, Massachusetts, United States Job Level : Mid-senior Designation : Director, Oncology Clinical Development at BioNTech SE
URL has been copied!

Insights For Selling To Cem

During A Call Or A Meeting

DO's

  • Talk anecdotally about the customer experience that your product offers
  • Use phrases like ‘people will love’, ‘massive impact’ etc.
  • Speak enthusiastically with energy, maintain a clear and confident tone

DONT's

  • Avoid overloading them with too much detail
  • Don’t push them to make a decision too fast, let them get comfortable first
  • Don’t assume a yes just because they have not said no

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Cem is

  • Relationship and rapport can play an important role, sometimes more than the other factors.
  • Will you ever get a clear answer from Cem

  • They will probably never say no directly, you have to make that decision yourself.

Insights For Deal Planning

    How fast (or slow) will Cem move?

  • They are not the quickest decision makers, their friendly attitude could be misleading.
  • Can Cem take some risk or not?

  • They can take certain risks that are unlikely to have personal consequences.

You And Cem

Personality Compatibility


Other BioNTech SE Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.